Today’s PM360 Panorama featured an article “Fifteen Ways Pharma Can Take Advantage of Twitter’s Redesign.” My comments were featured in the article, and the full article is here. Below are some further thoughts on the redesign and its applicability for pharma. With a full header image and stats on friends and photos, I can hardly [...]
Mark Davis
April 27, 2014
I recently stumbled across the Indie Web movement, First, I love the name. Rather than being a bunch of geek bloggers sniffing around the fringes, you’re now an Indie Band vs. a mainstream commercial act. That gets to the spirit of things – the Internet and simple self-publishing tools made it possible for passionate and [...]
Mark Davis
February 24, 2014
Do you keep your bookmarks in your browser? I did too – about 2,000 of them, until I suddenly had 1,600. Only, it wasn’t so sudden. Gradually, entire directories became empty, but they were bookmarks I used infrequently, and it happened over a period of months. So, I didn’t notice for a long while. What [...]
Mark Davis
January 17, 2014
Early Monday morning, the FDA released guidance for review on Interactive Promotional Media. This was the first tangible guidance since the FDA hearings on Pharma Social Media in November 2009, and for some this was a real occasion to open the champagne. Bill Evans at the industry leading Dose of Digital was the first to [...]
Mark Davis
October 26, 2013
Last week I went to Digital Pharma East. I was looking forward to connecting with a bunch of people I knew in a short amount of time. I knew I’d want to give them my updated contact information, and I started thinking about how I would do that. I know what you’ll say – just [...]
The last time I demonstrated LinkedIn company pages to a senior executive, with the goal of getting him to do it for his company, he was incredulous that it was free. He was looking for the price tag. It’s odd that in the rush to cover all the leading social media platforms that companies have neglected [...]